All News

Trends and comfort levels have changed among consumers, pharmacies, and payers from 2019 to 2020 as it relates to pharmacist-provided services and value-based performance programs.

Pharmacists should familiarize themselves with these therapies to help patients lessen the risk of emergency department visits and hospitalizations.

A review of the biologics license application for lisocabtagene maraleucel in the treatment of relapsed/refractory large B-cell lymphoma following at least 2 previous therapies has been delayed.

Although it is commonly known that children experience bullying over food allergies, new research suggests that parents and guardians do as well.

Although the announcement comes when many patients are trying to avoid unnecessary trips to stores or physicians’ offices, the offerings of Amazon will have a massive impact on traditional retail pharmacies.

Approximately 5% of women with kidney failure use contraceptives, which could lead to unintentional pregnancies in this high-risk group.

Individuals who regularly consume chili peppers may live longer and may have a significantly reduced risk of dying from cardiovascular disease or cancer

Patients may develop a vitamin C deficiency over the course of their COVID-19 illness, since vitamin C is consumed at a more rapid rate if an infection is active.

PD-L1 IHC 22C3 pharmDx will aid in the identification of patients with triple-negative breast cancer eligible for treatment with pembrolizumab.

A CDC report reveals that approximately 9% of teens between the ages of 15 and 19 received an opioid prescription in 2018.

With more awareness of the susceptibility to coinfection with varicella zoster virus and pneumocystic jirovecii, clinicians should aggressively seek signs of opportunistic infections in susceptible patients and treat them accordingly.

This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.

Moderna’s novel coronavirus disease 2019 vaccine candidate, mRNA-1273, showed 94.5% efficacy in preventing the virus, according to preliminary results from the ongoing phase 3 COVE trial.

In the study, more patients with allergies had chronic obstructive pulmonary disease (COPD), which is a known risk factor for severe disease with COVID-19.

A brain circuit that is critical for maintaining motivation may be responsible for a decline in learning as people age.